跳至主要内容
临床试验/ACTRN12614001241628
ACTRN12614001241628终止3 期

Prevention of recurrent pre-eclampsia by folic acid supplementation in pregnant women with hyperhomocysteinaemia.

Women's and Children's Hospital0 个研究点目标入组 626 人开始时间: 2014年11月26日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
入组人数
626

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Singleton pregnancy between > or = 12 and < or = 20 weeks gestation; past history of severe pre-eclampsia; hyperhomocysteinaemia (>11 umol in pregnancy, >13 outside pregnancy).

排除标准

  • No known vitamin B12 deficiency; no epilepsy taking anticonvulsants; no known homocystinuria; no multiple pregnancy; no medical need for folate supplementation.

研究者

发起方
Women's and Children's Hospital

相似试验